1. Introduction {#sec0005}
===============

Across the lifespan, problematic substance use has been linked to impairments in inhibitory control: the ability to regulate prepotent behaviors to facilitate goal-directed behaviors ([@bib0110]). However, substance use initiation and escalation typically begin during adolescence ([@bib0160]), when inhibitory control is still developing and ongoing brain maturation and specialization support the transition to adulthood ([@bib0180]; [@bib0225]). To this end, it has been suggested that diverging developmental trajectories of inhibitory control and other higher-order cognitive functions may increase vulnerability to problematic substance use ([@bib0040], [@bib0265]), by way of early substance use experimentation ([@bib0160]) and individual differences in psychiatric symptoms ([@bib0235]) that frequently co-occur with problematic substance use ([@bib0175]; [@bib0140]). Supporting this perspective, recent work from our group has demonstrated that substance use risk factors, specifically externalizing psychopathology and impulsivity, are associated with poor inhibitory control and cortical activation differences among adolescents during an antisaccade task([@bib0280]). However, it remains unclear whether certain periods of development are more sensitive to inhibitory control limitations associated with substance use vulnerability and if youth at risk for substance use follow different trajectories of neurocognitive development.

Neuroimaging studies suggest that the protracted development of inhibitory control during adolescence relies on functional changes in brain regions supporting cognitive control across the lifespan, including dorsolateral prefrontal cortex, posterior parietal cortex, and the anterior cingulate cortex ([@bib0055]; [@bib0190]). Supporting a potential role of these regions in vulnerability to problematic substance use, poor response inhibition and reduced activation within the prefrontal cortex during inhibitory control tasks have been shown to predict problematic substance use in adolescence ([@bib0215]; [@bib0210]). Similarly, prior work demonstrates that, relative to healthy controls, adolescents with a family history of substance use disorders, who have an increased risk for problematic substance use ([@bib0050]), exhibit divergent age-related activation differences within brain regions supporting inhibitory control, including the middle cingulate and frontal gyrus ([@bib0125]). However, the field has yet to evaluate such relationships within the context of broader substance use risk factors, including dimensional measures of psychopathology. This prevents a comprehensive understanding of the developmental etiology of problematic substance use. Furthermore, given that earlier substance use initiation is associated with increased risk for substance use dependence, previous work suggests that early adolescence may represent a sensitive period for substance abuse ([@bib0165]). Thus, characterizing the extent to which certain substance use risk factors might be associated with developmental differences in inhibitory control during distinct periods of adolescence is critical for developmentally-informed prevention and intervention ([@bib0075]).

Leveraging a large longitudinal sample that performed an antisaccade inhibitory control task during fMRI acquisition as part of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) study, the current project characterized developmental differences in inhibitory control associated with substance use risk factors, including externalizing and internalizing psychopathology and family history of substance use disorder. Based on previous work implicating poor response inhibition in externalizing psychopathology, a latent construct characterized by behavioral undercontrol and impulsivity ([@bib0145]), and prior work examining non-developmental main effects of externalizing psychopathology and impulsivity within a subset of the current sample ([@bib0280]), we predicted that externalizing psychopathology would be associated with poor inhibitory control and reduced activation in regions supporting cognitive control, including the prefrontal cortex. Critically however, and novel to the current project, we further hypothesized that at-risk youth would follow developmental trajectories of inhibitory control that diverged from normative patterns, as would be predicted by current theories suggesting that neurodevelopmental limitations in cognitive control may underlie adolescent substance use vulnerability ([@bib0035]).

2. Methods {#sec0010}
==========

2.1. Participants {#sec0015}
-----------------

Participants were part of the University of Pittsburgh Medical Center Site of the NCANDA study. See [@bib0030] for complete study protocol. Briefly, an accelerated longitudinal design was used to study adolescent brain development starting at various baseline ages (12--21 years of age) with longitudinal follow ups. At the time of manuscript preparation, data collection included up to three time points (i.e., baseline and two annual follow-ups). In the interest of studying substance use risk and eventual initiation and escalation, initial enrollment for the NCANDA study targeted youth at risk for substance use based on measures of psychopathology and family history of substance use disorders (see **2.2**) but with limited substance use. The study aimed to achieve a sample that consisted of approximately 50 % of participants at risk for substance use. Exclusion criteria included contraindications to magnetic resonance imaging (MRI; e.g., non-removable metal implements), medical history that would compromise MRI (e.g., traumatic brain injury), and a current or persistent major psychiatric disorder that would interfere with testing (e.g., psychosis). The study protocol was approved by the University of Pittsburgh Institutional Review Board. Informed consent and assent were obtained from adults and minors, respectively. Participants were compensated for their participation.

After excluding testing sessions (subject at visit) based on study-specific criteria (see **2.4** for behavioral exclusion criteria), the final sample for the current project included 113 participants (baseline age ranged from 12.27 to 21.96, M = 17.11, SD = 2.66). For the behavioral analysis, a total of 220 sessions were included. Among the sample, 41.6 % (n = 47) of subjects had data which met study-specific inclusion criteria for baseline and follow-up and 26.5 % (n = 30) had data which met study-specific criteria at all three time points. The final neuroimaging sample included 104 participants and a total of 183 sessions, with 45.6 % (n = 47) of the sample having data at both baseline and follow-up and 15.4 % (n = 16) of the sample having data across all three visits (see **2.6.2** for neuroimaging exclusion criteria). See [Fig. 1](#fig0005){ref-type="fig"} for sample age distribution and [Table 1](#tbl0005){ref-type="table"} for sample characteristics.Fig. 1Age distribution of sample. Primary behavioral sample included 113 participants and a total of 220 sessions. Top: Longitudinal structure of the project, where horizontal lines connect subjects' visits (filled circles). Bottom: Density plot of subject age across all visits.Fig. 1Table 1Sample characteristics.Table 1BaselineSecond VisitThird Visit*N*947947Female (%)59.5753.1644.68Age^a^17.11 (2.66)18.46 (2.48)19.09 (2.51)Generalized Cognitive Ability (z-score)^a,\ b^−0.01 (0.85)0.03 (0.87)0.25 (0.76)Socioeconomic Status^a^89.63 (14.11)88.41 (15.32)91.36 (13.68)Race (%)Caucasian82.9882.2891.49Non-Caucasian17.0217.718.51Substance useExceeds Threshold Drinking^b^ (*n*)24208Risk FactorsExternalizing T-score^a,\ c^42.91 (8.14)43.97 (8.71)41.49 (8.81)Internalizing T-score^a,\ c^45.02 (9.41)45.25 (9.55)41.57 (10.36)Family history of substance use disorder^b^ (*n*)16189[^2]

2.2. Measures {#sec0020}
-------------

### 2.2.1. Substance use {#sec0025}

The primary focus of the current study was to characterize developmental trajectories of substance use risk factors. Thus, problematic substance use examined as a covariate in all analyses in order to account for inhbitory control differences that may be related to problematic substance use ([@bib0130]). This variable was defined at baseline using an established scoring protocol from the Customary Drinking and Drug Use Record (CDDR; [@bib0025]), where substance use was coded categorically and indicated whether participants exceeded age-specific National Institute on Alcohol Abuse and Alcoholism (NIAAA) guidelines for risky drinking (Exceeds Threshold Drinking; ETD; n = 29). This variable was selected for primary analysis to match our work with this sample using baseline and one-year follow-up data ([@bib0280]). Furthermore, problematic substance use beyond this baseline characterization was uncommon in the final behavioral sample (weekly binge drinking: n = 17, weekly marijuana use n = 14; see Supplementary Methods for details), reflecting the isolation of substance use risk and relatively minimal levels of problematic substance use at this stage of the Pittsburgh NCANDA sample.

### 2.2.2. Substance use risk factors {#sec0030}

Constructs indexing substance use risk in the current project, externalizing and internalizing psychopathology and family history of substance use disorder, were defined with regard to the original design of NCANDA (see [@bib0030]). Externalizing (EXT) and internalizing (INT) psychopathology were assessed using the Achenbach System of Empirically Based Assessments (ASEBA; [@bib0005]). Participants younger than 18 completed the Youth Self-Report (YSR), while participants older than 18 completed the Adult-Self-Report after the age of 18 (ASR). Critically however, these scales are designed to measure the same latent externalizing and internalizing structures, but with developmentally-appropriate questions. Age and gender adjusted t-scores were used as continuous measures for both EXT and INT. The ASEBA measures were collected at each visit. Family history of substance use disorder was assessed using the Family History Assessment Module ([@bib0245]) and was defined at baseline as having at least one biological parent or grandparent with substance use disorder symptoms (FH; *n* = 22). See [Table 2](#tbl0010){ref-type="table"} for correlations amongst substance use risk factors and other study variables.Table 2Correlations amongst risk and sociodemographic factors of interest.Table 2EXTINTFHETDAgeSESGAGenderEXT---PearsonPolyserialPolyserialPearsonPearsonPearsonPolyserialINT**0.517\*\*\***---PolyserialPolyserialPearsonPearsonPearsonPolyserialFH0.1840.134---PolychoricPolyserialPolyserialPolyserialPolychoricETD**0.298\*\***0.0120.181---PolyserialPolyserialPolyserialPolyserialAge0.0980.066−0.005**0.520\*\*\***---PearsonPearsonPolyserialSES**−0.178\***−0.118−0.1420.0670.080---PearsonPolyserialGA0.065−0.0270.0780.192**0.427\*\*\*0.408\*\*\***---PolyserialGender0.007−0.029**−0.338\***0.0210.129−0.035−0.044---[^3]

### 2.2.3. Generalized cognitive ability and sociodemographic factors {#sec0035}

A composite measure of cognitive function, generalized cognitive ability accuracy (GA), was assessed with the Penn Computerized Neurocognitive Battery ([@bib0115]) and "paper and pencil" neuropsychological tests ([@bib0270]). GA was used as a covariate (see **2.5** for covariate procedures) in analyses of inhibitory control performance and brain activation in order to provide broader context of any developmental patterns of substance use risk factors associated with antisaccade performance. This covariate is critical within the context of previous work characterizing antisaccade performance and inhibition as a domain-general cognitive function ([@bib0200]). Specifically, since the GA measure evaluates several cognitive domains, this score allowed us to examine whether the developmental associations of substance use risk factors with antisaccade performance were specific to inhibitory control, while accounting for general differences in cognition. Similarly, gender and Socioeconomic Status (SES; [@bib0135]), which was measured as a composite of parental education and income, were also examined as covariates to provide broader sociodemographic context of substance use vulnerability (cf., [@bib0275]). GA and SES information were defined from baseline visit data. Sessions missing GA (n = 2) and SES (n = 14) data were excluded from analyses examining these variables.

2.3. Rewarded antisaccade task {#sec0040}
------------------------------

Participants completed a rewarded antisaccade task during fMRI acquisition initially described by Geier et al. (2010; [Fig. 2](#fig0010){ref-type="fig"}) and reported in prior work from our group on an earlier portion of this sample ([@bib0280]). Briefly, each trial consisted of cue, preparation, and response epochs lasting 1.5 s each. During the cue epoch, participants viewed a white fixation cross surrounded by a ring of green "\$" symbols, indicating that a trial would be rewarded if a correct antisaccade was performed, or a ring of blue "\#", indicating a neutral trial in which no money was at stake. The preparation epoch was indicated by a red fixation cross and prompted participants to prepare for the response epoch, during which participants were to make a saccade in the mirror location of a yellow dot that appeared in unpredictable locations along the horizontal meridian at 1 of 6 eccentricities (±3, 6, and 9 degrees visual angle, relative to fixation). In addition to these "full trials", additional partial trials, which consisted of either solely the cue epoch or the cue and preparation epochs but not the response epoch, were presented in order to aid in the estimation of hemodynamic responses evoked during each epoch ([@bib0220]; see **2.6.4**). Participants completed four neuroimaging runs, each consisting of 28 full trials (14 neutral, 14 reward) and 12 partial trials (3 of each partial trial by reward type). Prior to starting the task, participants were told that they could earn up to \$25.00 but were not informed of the exact amount of monetary rewards for each correct trial. This was done to prevent participants from tallying their earnings, potentially engaging non antisaccade-specific brain systems (e.g., working memory).Fig. 2Rewarded antisaccade task ([@bib0100]).Fig. 2

2.4. Eye movement measurement and scoring {#sec0045}
-----------------------------------------

Antisaccade task stimuli were presented using E-Prime on a flat screen positioned behind the MRI scanner, which was visible to the participant through a mirror mounted on the MRI head coil. Eye movements were tracked using a long-range optics eye-tracking system (Applied Science Laboratories, Bedford, MA) that recorded eye positions through corneal reflections. At the beginning of each experimental session, a 9-point calibration was conducted to ensure accurate characterization of saccades for each participant.

Antisaccade scoring followed the same procedure as prior work from our group ([@bib0230]; [@bib0280]). A correct antisaccade was defined by an eye movement with a velocity of at least 30 degrees/s and 2.5 ° visual angle from central fixation to the mirror location of the peripheral target ([@bib0105]). Antisaccade errors were defined as those with an initial saccade toward the target that extended at least 2.5° visual angle (i.e. prosaccade). An error corrected trial was specified by an initial saccade toward the target and extended at least 2.5° visual angle from central fixation followed by a correct antisaccade to the mirror location. In the current project, both antisaccade errors and error-corrected antisaccades were considered errors in both behavioral and neuroimaging analyses. Trials in which the participant failed to make any saccade or had poor eye tracking were considered dropped trials and were excluded from all analyses. Testing sessions (subject at visit) were excluded from both behavioral and neuroimaging analyses if the proportion of dropped trials exceeded 30 % and/or if 50 % of total trials were dropped or missing due to incomplete acquisition. The overall proportion of dropped trials was low across visits (10.6 % at baseline, 11.3 % at the second visit, and 10.9 % at the third visit) and was not associated with substance use risk factors (Supplementary Table 1).

2.5. Antisaccade behavioral performance {#sec0050}
---------------------------------------

Behavioral analyses were performed in R 3.1.2 ([@bib0240]). Generalized mixed-effects regression models with a logit link function (lme4 package in R, [@bib0015]) were used to predict antisaccade correct response rate across trial-wise data. This logit link function was appropriate considering the binomial structure of the trial-level data (correct vs. incorrect). Critically, the use of generalized mixed effect models with trial-wise data reduces ceiling effects in mean accuracy distributions ([@bib0085]). Random intercepts were estimated for each subject. Reward conditions (reward, neutral), age, visit, ETD, and substance use risk factors (EXT, INT, FH) were entered as fixed effects in a series of models (see below). Antisaccade latencies were modeled similarly but using linear mixed effects models and only included correct trials. Significance values were obtained through the Car package in R ([@bib0095]). Potential leverage points were examined on session-mean performance metrics using cook's distance with a threshold of 1. Only one session (subject at visit) exceeded this threshold and the pattern of significant results was unchanged when excluding this session. Consequently, this session was retained in the final analyses.

Due to correlations among risk factors, a series of models were employed. First, to examine main effects, the association between antisaccade performance and each risk factor was first modelled separately. Next, given the interest in studying developmental trajectories of inhibitory control amongst substance use risk factors, each risk factors' interaction with age was examined. Subsequently, in order to address the specificity of results, all other risk factors were included as covariates. Lastly, to account for sociodemographic effects and general cognitive differences, GA and SES were included as covariates in both main effect and interaction models. Unless otherwise noted, inferences are drawn only on those risk factors that remain significant across all models.

2.6. fMRI {#sec0055}
---------

### 2.6.1. Acquisition {#sec0060}

Neuroimaging data were collected at the Magnetic Resonance Research Center at the University of Pittsburgh on a 3.0-T Siemens Magnetom TIM Trio. A magnetization prepared rapid acquisition gradient-echo (MP-RAGE) pulse sequence with 160 slices (1.2 × 0.938 × 0.938) was used to create structural images for functional registration and conversion into a standardized template. Blood-oxygen-level-dependent (BOLD) data were acquired using an axially acquired echo-planar imaging (EPI) sequence (field of view = 200 mm, 64 × 64 matrix, 3.125 × 3.125 × 3.200 mm anisotropic voxels, 29 slices, TR = 1.5 s, TE =28 ms, flip angle = 73°).

### 2.6.2. Preprocessing {#sec0065}

Preprocessing of fMRI data followed the same procedures as other recent task-based fMRI from our group ([@bib0230]; [@bib0255]; [@bib0280]). This included the removal of motion and noise artifacts (Analysis of Functional Neuroimages, AFNI; 3dDespike; [@bib0065]), non-linear registration of functional data to a standardized structural brain (3 mm, MNI-152 template; 2009c), slice timing and motion correction (mcflirt; [@bib0150]). Data was then smoothed with FWHM of 5 mm (SUSAN; [@bib0260]) and a 0.00625 Hz high-pass filter was applied. Finally, data was scaled by 10,000 of the global median. Sessions were excluded if session-wise mean Euclidean norm head motion exceeded 0.9 mm (n = 5), there was poor EPI coverage across runs upon visual inspection (n = 3), or due to technical error (n = 8).

### 2.6.3. Trial-level fMRI analysis {#sec0070}

Consistent with prior work using a subset of this sample ([@bib0280]), we estimated BOLD responses at both the trial and epoch level. To estimate average trial-level BOLD responses, a general linear model estimating BOLD activation was generated using AFNI's 3dDeconvolve tool. Trial types (reward, neutral) were modelled separately with a 4,500 ms boxcar convolved with a gamma function (AFNI\'s block 4). Individual regressors for correct, error-corrected, and dropped trials were modeled for each trial condition. We note that incorrect non error-corrected: **see 2.4**) antisaccades were rare in the sample overall (less than 1 % of total trials) and did not occur in all subjects (69/104). Therefore, in order to ensure consistency of modeling across all subjects, these trials were modeled with the dropped trials. Partial trials were modelled similarly but with a 1,500 ms boxcar for cue partial trials and 3000 ms boxcar for cue and preparatory partial trials. Six rigid-body head motion parameters, their first order derivatives, as well as run-wise 0 through 3^rd^ order polynomials were included as nuisance regressors. TRs were censored if Euclidean norm head motion exceeded 0.9 mm.

### 2.6.4. Epoch-level fMRI analysis {#sec0075}

Previous research has shown that BOLD activation varies amongst the epochs of this rewarded antisaccade task as participants assess reward contingencies, prepare a response, and execute an antisaccade response ([@bib0100]). Therefore, we also estimated the BOLD response within individual epochs in a second model. Each epoch (cue, preparation, and response) was modeled as a separate regressor with a boxcar (1.5 s duration, scaled to an amplitude of 1; AFNI's block 4) and convolved with a gamma function. Correct, error-corrected, and dropped/incorrect trials were modeled separately for each trial condition (Reward, Neutral) and each epoch. Partial trials were included as examples of each epoch to aid in the estimation of epoch-specific BOLD response ([@bib0220]). Nuisance regressors and motion censoring methods followed the same procedure as the trial-level deconvolution.

### 2.6.5. Voxelwise Analysis {#sec0080}

We examined main effects of substance use risk factors and their interactions with age in whole-brain voxelwise analyses predicting BOLD activity during correct antisaccade trials (AFNI's 3dlme; [@bib0045]). All fMRI analyses covaried for session-wise mean Euclidean norm head motion, visit number, and trial type (reward, neutral). Each model was tested on both trial-level and individual epoch-level BOLD parameter estimates. Voxelwise testing was limited to voxels with at least a 50 % probability of being gray matter in the MNI-152 template and full EPI coverage across the sample. Multiple comparison correction was conducted using a combination of cluster size and voxel significance. Parameters for thresholding were determined using AFNI's updated 3dClustSim program (acf option), which determines cluster size threshold through Monte Carlo simulations based on averaged spatial autocorrelation parameters. Autocorrelation parameters were estimated from residuals of the subject-level deconvolution models with AFNI's updated 3dfwhmx tool (acf option). This analysis specified that at least 20 contiguous voxels (faces-touching, AFNI's NN1) initially thresholded at p = .005 were necessary to achieve cluster-level corrected alphas of less than 0.05 for both trial-level and epoch-level analyses.

3. Results {#sec0085}
==========

3.1. Antisaccade behavioral performance {#sec0090}
---------------------------------------

### 3.1.1. Reward and age effects {#sec0095}

The average antisaccade correct response rate (accuracy) was 78.85 % (SD = 15.69 %) and the average latency was 438.53 ms (SD =57.5 ms). Both accuracy (z = 4.98, *X^2^~(1)~* = 24.78, p \< 0.001) and latency (t =-3.66, *X^2^~(1)~* = 13.36, p \< 0.001) robustly improved with age (higher accuracies and shorter latencies with increasing age). Consistent with prior work using this task (Geier et al., 2010) and analyses within a subset of this sample ([@bib0280]), rewarded trials were associated with greater correct response rates (z = 9.23, *X^2^~(1)~* = 85.01, p \< 0.001) and shorter latencies (t =-7.60, *X^2^~(1)~* = 57.37, p \< 0.001). Given that our prior work with a subset of this sample ([@bib0280]) and the current project revealed non-significant interactions between reward conditions and substance use risk factors (Supplementary Table 2), additional higher-order interactions with trial type (reward, neutral), age, and risk-factors, were not explored. However, trial type was treated as a covariate in all behavioral and neuroimaging analyses.

### 3.1.2. Main effects of substance use risk factors {#sec0100}

*Accuracy.* When considering main effects across the sample, both EXT (*z* = -2.05, *X^2^~(1)~* = 4.21, *p* = 0.04) and INT (*z* =-3.24, *X^2^~(1)~* =10.51, *p* = 0.001) had negative relationships with AS correct accuracy, suggesting that higher levels of these risk factors are associated with poorer antisaccade performance. Only INT (*z* =-2.16, *X^2^~(1)~* = 4.68, *p* = 0.02) continued to negatively be associated with AS accuracy when all risk factors were considered in a joint model. Both EXT (*z* = -2.15, *X^2^~(1)~* = 6.31, *p* = 0.01) and INT (*z* = -3.58, *X^2^~(1)~* = 12.82, *p* \< 0.001) continued to be negatively associated with AS accuracy when covarying for GA and SES. FH and ETD did not predict AS accuracy ([Table 3](#tbl0015){ref-type="table"}).Table 3Main effects and age interactions predicting antisaccade performance.Table 3EXTINTFHETDAgeGASESGenderAccuracy (z)Main effect**−2.05\*^b^−3.24\*\*^a,b^**−1.131.02**4.98\*\*\*^a,b^2.94\*\*^a,b^**0.60−0.06Age interaction**2.48\*^a,b^**1.35−1.88−0.38---**−3.08\*\*^a,b^−2.66\*\*^a,b^**−0.05Latency (t)Main effect−1.20**−3.01\*\*^a,b^**−1.100.21**−3.66\*\*\*^a,b^**0.880.43**3.82\*\*^a,b^**Age interaction**3.63\*\*\*^a,b^**0.47−0.100.77---1.39−.43−1.0[^4]

*Latency of correct trials.* Greater INT scores (*t* =-3.01, *X^2^~(1)~* = 9.04, *p* = 0.003) were associated with shorter latencies. This relationship remained significant when considering all other risk factors (*t* = -2.22, *X^2^~(1)~* = 4.95, *p* = 0.006). Further, INT (*t* = -3.62, *X^2^~(1)~* = 13.14, *p \<* 0.001) continued to be negatively associated with latency when controlling for GA and SES. EXT, FH, and ETD were not associated with main effects of latency ([Table 3](#tbl0015){ref-type="table"}). As in the accuracy analyses, no other risk factors had significant interactions with age associated with latency.

### 3.1.3. Risk factor interactions with age {#sec0105}

*Accuracy*. EXT significantly moderated age-related improvements in AS accuracy (*z* = 2.48, *X^2^~(1)~* = 6.15, *p* = 0.013, [Fig. 3](#fig0015){ref-type="fig"}a). The Johnson-Neyman technique, which specifies intervals of significance within continuous by continuous interaction terms ([@bib0155]), indicated that greater EXT scores were associated with poorer AS accuracy in early adolescence until normalizing to the rest of the sample at approximately 17 years old ([Fig. 3](#fig0015){ref-type="fig"}a). The interaction between EXT and age remained significant when accounting for INT, FH and ETD (*z* = 2.64, *X^2^~(1)~* = 6.99, *p* = 0.008), as well as when covarying for GA and SES (*t* = 2.00, *X^2^~(1)~* = 3.99, *p* = 0.046). No other risk factors had significant interactions with age.Fig. 3\*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001. Individual differences in externalizing psychopathology (EXT) moderate age-related improvements in antisaccade accuracy (Panel A, left) and latency (Panel B, left). For Johnson-Neyman plots (generated from interactions R package; [@bib0185]), darker blue colors reflect significant effects of EXT (p \< 0.05) predicting antisaccade performance during the indicated age ranges (Panel A Panel B right). Shaded regions represent 95 % confidence intervals.Fig. 3

*Latency of correct trials*. EXT also moderated age-related change in latency, where greater EXT scores were associated with reduced latency in early adolescence (*t* = 3.63, *X^2^~(1)~* = 13.18, *p* \< 0.001; [Fig. 3](#fig0015){ref-type="fig"}b). This relationship persisted when covarying for all other risk factors (*t* = 3.96, *X^2^~(1)~* = 15.69, *p* \< 0.001) and when accounting for GA and SES (*t* = 2.84, *X^2^~(1)~* = 8.06, *p* = 0.004). As in the accuracy analysis, no other risk factors had significant interactions with age.

*Speed-Accuracy Relationships in Externalizing Psychopathology.* Given the evidence for high externalizing participants to have lower accuracy and shorter latencies in correct responses during early adolescence, we performed a secondary analysis to examine potential speed-accuracy trade-offs as a function of externalizing psychopathology and age. This analysis revealed a significant three-way interaction between latency, age, and EXT when predicting correct response rate (*z* = 3.04, *X^2^~(1)~* = 9.27, *p* = 0.002) such that there was a significant relationship between externalizing psychopathology, latency and accuracy only in early adolescence. Specifically, in early adolescence, externalizing scores were associated with decreased antisaccade accuracy and these accuracy differences were largest for longer latencies. Thus, these results were not consistent with a typical speed-accuracy trade-off, where a lower correct response rate is driven by shorter latencies. See Supplementary Fig. 1 for visualization of accuracy and latency as a function of age and externalizing.

### 3.1.4. Sociodemographic relationships {#sec0110}

Females had significantly shorter latencies (*t* = 3.82, *X^2^~(1)~* = 14.55, *p* \< 0.001). Greater GA scores were associated with improved accuracy (*z* = 2.94, *X^2^~(1)~* = 8.64, *p* = 0.003). Further, GA (*z* = -3.08, *X^2^~(1)~* = 9.40, *p* = 0.002; Supplementary Fig. 2a.) and SES (*z* = -2.66, *X^2^~(1)~* = 7.09, *p* = 0.008; Supplementary Fig. 2b.) interacted with age to predict antisaccade accuracy, with patterns that mirrored the interaction between EXT and age.

3.2. Functional neuroimaging {#sec0115}
----------------------------

### 3.2.1. Head motion {#sec0120}

As has been well-described in previous developmental research, head motion was greater at younger ages (*t* =-2.74, *X^2^~(1)~* = 7.55, *p* \< 0.001). No risk factors were associated with head motion or interacted with age to predict head motion. However, as described in the methods section, TRs during which Euclidean norm head motion distances exceeded 0.9 mm were excluded and all fMRI analyses covaried for average session-wise Euclidean norm head motion.

### 3.2.2. Main effects of substance use risk factors {#sec0125}

In the interest of studying developmentally-relevant brain-behavior relationships, only significant main effects and risk factor by age interactions from the behavioral analyses were followed-up in neuroimaging analyses. At the trial-level, greater EXT scores predicted decreased activation in the left middle frontal gyrus ([Fig. 4](#fig0020){ref-type="fig"}; Supplementary Table 3). Average activation within this cluster had a positive relationship with antisaccade accuracy (proportion of correct trials; *t* = 2.50, *X^2^~(1)~* = 6.23, *p* = 0.01), suggesting hypo-activation in this region was task-relevant to performance. EXT was also a negative predictor of BOLD activation in the right superior temporal gyrus (Supplementary Table 3). Among individual epochs, EXT was positively associated with BOLD activity within the thalamus during the preparatory epoch and had negative relationships with BOLD activation across frontoparietal regions during the response epoch (Supplementary Table 3).Fig. 4Greater externalizing scores are associated with decreased trail-wise BOLD activation in the left middle frontal gyrus (left). This association did not significantly interact with age (right). Shaded regions represent 95 % confidence intervals. Voxelwise threshold p \< .005, number of contiguous voxels \> 20, p \< 0.05 corrected.Fig. 4

Specifically among trial-level data, greater INT scores were associated with decreased activity in frontoparietal regions (inferior parietal lobule, precuneus, middle frontal gyrus; Supplementary Table 3) and greater GA scores predicted increased activity in the left precuneus (Supplementary Table 3).

### 3.2.3. Risk factor and sociodemographic interactions with age {#sec0130}

At the trial-level, there was a significant GA and age interaction in the right middle frontal gyrus ([Table 4](#tbl0020){ref-type="table"}; Supplementary Fig. 3) such that greater GA scores predicted decreased activity in this region with increasing age. Average activation within this cluster was a positive predictor of antisaccade accuracy (*t* = 2.25, *X^2^~(1)~* = 5.04, *p* = 0.025). Further, SES interacted with age to predict BOLD activity in the inferior parietal lobule such that greater SES was associated with decreased activity in this region with increasing age ([Table 4](#tbl0020){ref-type="table"}; Supplementary Fig. 3).Table 4Age interactions of substance use risk and sociodemographic factors in BOLD activation.Table 4MNIVariableEpochRegionBAkxyztEXTCueL Posterior Parietal Cortex722−29−71314.26GATrial-wiseR Middle Frontal Gyrus62631−861−4.27PreparatoryR Precuneus312013−5922−4.14L Precuneus720−2−7437−3.89ResponseR Insula138340−8195.44L Precuneus3120−20−62254.03SESTrial-wiseL Inferior Parietal Lobule4024−59−4125−4.37CueL Angular Gyrus3920−53−68343.71PreparatoryL Inferior Parietal Lobule2234−59−3822−5.36[^5]

At the epoch-level, EXT moderated age-related BOLD activity within the left posterior parietal cortex ([Table 4](#tbl0020){ref-type="table"}; [Fig. 5](#fig0025){ref-type="fig"}) in the cue epoch. Mean activation within this cluster did not predict antisaccade accuracy (proportion of correct trials; *t* = 0.46, *X^2^~(1)~* =0.21, *p* = 0.65) or latency (*t* = 1.24, *X^2^~(1)~* =15.40, *p* = 0.21). Mirroring similarities with EXT in behavioral data, GA and SES also interacted with age to predict BOLD activation within individual epochs. Specifically, greater GA scores were associated with decreased activation with increasing age in bilateral precuneus in the preparatory epoch but were associated with increased activation with increasing age in the left precuneus and right insula during the response epoch ([Table 4](#tbl0020){ref-type="table"}; Supplementary Fig. 4). Greater SES scores were associated with increased activity in the left angular gyrus with increasing age during the cue epoch but decreased activity with increasing age in the left inferior parietal lobule during the preparatory epoch ([Table 4](#tbl0020){ref-type="table"}; Supplementary Figs. 5).Fig. 5Externalizing psychopathology (EXT) by age interaction in the left posterior parietal cortex during the cue epoch. Voxelwise threshold p \< .005, number of contiguous voxels \> 20, p \< 0.05 corrected (left). For Johnson-Neyman plot of interaction, darker blue colors reflect significant main effects of EXT (p \< 0.05) predicting BOLD signal during the indicated age ranges (right). Shaded regions represent 95 % confidence intervals.Fig. 5

4. Discussion {#sec0135}
=============

The purpose of the current study was to examine the relationship between age-related trajectories of inhibitory control and substance use risk factors. Our findings indicate that higher levels of externalizing psychopathology are associated with lower accuracy and shorter latencies in early adolescence that normalized at later ages. Neuroimaging results revealed that externalizing psychopathology was associated with both hypo-activation in the middle frontal gyrus at all ages and age-related increases in posterior parietal cortex activation during early adolescence.

4.1. Substance use risk factors and developmental improvements in inhibitory control {#sec0140}
------------------------------------------------------------------------------------

We found that greater externalizing scores were associated with lower correct response rates in the antisaccade task. This result is consistent with our previous findings within a subset of the current sample ([@bib0280]), and supports theories relating disinhibitory phenotypes of substance use risk with poor response inhibition ([@bib0145]; [@bib0300]). We further sought to investigate how the relationship between inhibitory control limitations and substance use risk changes developmentally. Consistent with previous work, antisaccade accuracy and latency improved throughout adolescent development ([@bib0225]). However, our findings indicate divergent developmental trajectories of inhibitory control with respect to the degree of substance use risk factors. Specifically, we show that greater levels of externalizing psychopathology were associated with poorer antisaccade accuracy and shorter latencies in early adolescence. However, secondary analyses revealed a nuanced relationship between latency and accuracy in high externalizing youth during early adolescence, where the largest differences in correct response rate where observed at longer latencies. Thus, these findings do not support a speed accuracy trade-off model of impulsivity in which high impulsivity is associated with rapid and error-prone responses in cognitive tasks ([@bib0080]). Rather, they may be consistent with differences in an overall response strategy that differentially emphasizes speed or accuracy, depending on task demands. Our results further suggest such response differences are most evident in early adolescence, followed by a pattern of equifinality. However, despite poor response inhibition in early adolescence, high externalizing scores were associated with accelerated age-related improvements in accuracy to establish normative performance levels by late adolescence. Similarly, shorter latencies in early adolescence normalized by late adolescence. These developmental differences may reflect shifts in strategies to optimize performance throughout development and compensate for inhibitory control limitations in early adolescence, as high externalizing youth gain more top-down control of behavior. To this end, additional work may more directly test developmental changes in speed-accuracy trade-offs and decision-making strategies in more explicit computational frameworks (e.g., drift diffusion modeling) in externalizing youth.

Although previous work implicates cognitive control deficits in youth with a family history of substance use disorder ([@bib0070]), this risk factor was not associated with differences in antisaccade performance in the current study. However, our analyses with this risk factor had limited statistical power due to few family history positive subjects within the sample. In contrast, and relatively unexpectedly, internalizing psychopathology was associated with low correct response rate and shorter latencies across development. More clarity on family history and internalizing psychopathology within inhibitory control paradigms will require future work examining broad multidimensional high-risk profiles (see **4.3**). Nevertheless, externalizing psychopathology was the only substance use risk factor that moderated age-related change in antisaccade performance, providing some support that externalizing psychopathology may be uniquely associated with developmental differences in inhibitory control. To this end, the externalizing by age interaction remained significant when covarying other risk factors, as well as generalized cognitive ability and socioeconomic status. Taken together, these results highlight early adolescence as a potential period of increased substance use vulnerability by way of developmental differences in response inhibition and disinhibitory phenotypes.

4.2. Substance use risk factors and brain systems supporting inhibitory control {#sec0145}
-------------------------------------------------------------------------------

Converging with previous research examining prospective prediction of substance use initiation and high-risk profiles, internalizing and externalizing substance use risk factors in the current project were associated with decreased BOLD activation across frontoparietal regions during response inhibition ([@bib0215]; [@bib0195]). Further, supporting previous work implicating poor top-down control in externalizing psychopathology ([@bib0020]), greater levels of externalizing psychopathology were associated with decreased trial-level activation in the left middle frontal gyrus. Given that this finding occurs at the trial-level and activation in this region predicted antisaccade accuracy, poor inhibitory control performance associated with high externalizing may be marked by limitations in broad inhibitory control processes mediated by the middle frontal gyrus. Further, this relationship may represent a general trait-level feature of externalizing psychopathology as it was stable across development. This relationship may also index a trait-level feature of general psychopathology as internalizing psychopathology was also associated with developmentally-stable decreased activation in frontoparietal regions. In contrast to common developmentally-stable effects, externalizing psychopathology was uniquely associated with developmental differences in posterior parietal cortex activity during the cue epoch of the antisaccade task, where high externalizing scores were associated with increasing activation with age in this region. The developmental association of posterior parietal cortex activation with externalizing psychopathology as a substance use risk factor is consistent with previous research showing that posterior parietal cortex activation differences are associated with adolescent substance use ([@bib0250]) and substance use vulnerability ([@bib0285]) and age of substance use initiation ([@bib0290]) during working memory tasks. Although the sign of activation may differ based on task demands, activation differences in the posterior parietal cortex may represent a common developmental neural correlate underlying substance use risk across cognitive tasks. Supporting this, the posterior parietal cortex is implicated in attentional control, a function supporting both working memory and inhibitory control ([@bib0060]; [@bib0295]). In addition, previous research has found that trait impulsivity is positively correlated with vulnerability to distraction by reward cues ([@bib0010]). Therefore, since parietal cortex activation differences related to externalizing psychopathology occurred during the incentive cue epoch, this finding may reflect developmental differences associated with orienting attention to reward contingency cues.

Previous work characterizing normative functional development of the parietal cortex indicates this region does not exhibit age-related changes during the antisaccade task ([@bib0225]) but its function decreases with age to support working memory development ([@bib0255]). Diverging from these patterns, greater levels of externalizing psychopathology were associated with increasing engagement of the posterior parietal cortex across development, which was not observed for low levels of externalizing psychopathology and in more normative subjects (cf., [@bib0225]). Given that differences in antisaccade performance associated with externalizing psychopathology are most evident in early adolescence and normalize with age, age-related increases in posterior parietal cortex activation may reflect a compensatory mechanism that serves to optimize performance across development. However, in the absence of a significant association between activity in this region and antisaccade behavioral performance, the functional contribution of parietal cortex activity to developmental differences in inhibitory control performance associated with externalizing psychopathology remains unclear. Future work may employ tasks targeting multiple cognitive functions (e.g., inhibition, attentional control: [@bib0010]; working memory: [@bib0290]) to examine general and specific activation patterns in the posterior parietal cortex that may underlie the developmental differences of cognitive control in risk for substance use.

4.3. Common and specific neurocognitive profiles of substance use risk factors {#sec0150}
------------------------------------------------------------------------------

In addition to characterizing development trajectories associated with substance use risk factors, we investigated developmental differences in broader sociodemographic factors, including generalized cognitive ability accuracy and socioeconomic status. Mirroring developmental differences associated with externalizing psychopathology, lower levels of generalized cognitive ability and socioeconomic status were associated with decreased antisaccade correct response rates in early adolescence that normalized in late adolescence and early adulthood. These results indicate a potential common developmental pattern of equifinality across sociodemographic and psychopathology risk factors. Taken together with previous work characterizing the interrelationships amongst socioeconomic status, executive functioning, and psychopathology ([@bib0120]; [@bib0170]), these results support theories suggesting substance use risk may best be represented using dimensional constructs encompassing multiple facets of risk factors (e.g., neurobehavioral disinhibition; [@bib0275]). However, our results also suggest that each risk factor may be associated with independent developmental processes underlying inhibitory control maturation. Supporting this, differences in age-related improvements in antisaccade *latency* was specific to externalizing psychopathology. Further, generalized cognitive ability, socioeconomic status, and externalizing psychopathology were associated with developmental differences in non-overlapping brain regions. Specifically, greater levels of generalized cognitive ability and socioeconomic status were associated with BOLD activity that decreased with age in the middle frontal gyrus and inferior parietal lobules, respectively. Thus, our data indicate potential compensatory mechanisms may be differentially relevant to each risk factor. Future research may further evaluate individual differences in neurocognitive mechanisms underlying developmental patterns of equifinality in inhibitory control common across substance use risk and sociodemographic factors.

4.4. Limitations {#sec0155}
----------------

The present study is characterized by a number of strengths, including a relatively large longitudinal neuroimaging sample and use of continuous measures of substance use risk factors. This approach allowed us to identify the relative magnitude of substance use risk factors and distinct age ranges in which differences in inhibitory control were most evident. Such a characterization of individual differences in inhibitory control across development and among multiple risk factors highlights the importance of studying dimensional constructs of psychopathology (Research Domain Criteria; [@bib0205]). However, in the current sample, a relatively small proportion of the sample exceeded the described threshold of alcohol use at baseline and few participants initiated problematic substance use at follow-up visits. This limited our ability to examine how problematic substance use initiation and escalation may perturb normative development of inhibitory control. Similarly, relatively few participants met criteria for a family history of substance use disorder. Therefore, our study was less powered compared to previous studies that have characterized developmental differences in youth with a family history of substance use disorder ([@bib0125]). With respect to previous work highlighting cognitive control deficits in youth with a family history of substance use disorder ([@bib0070]) and substance use initiation in adolescence ([@bib0130]), future research leveraging large-scale initiatives such as the Adolescent Brain Cognitive Development (ABCD) study and broader datasets within the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) will be critical in characterizing developmental differences associated with family history of substance use disorder and subsequent substance use escalation.

5. Conclusion {#sec0160}
=============

Our findings indicate that substance use risk factors are associated with developmental differences in inhibitory control. Specifically, externalizing psychopathology was associated with decreased correct response rates and shorter latencies in early adolescence that appear to resolve into adulthood, perhaps through compensatory mechanisms acquired during adolescence. Neuroimaging data reveal high externalizing psychopathology was associated with developmentally-stable hypo-activation in prefrontal cortex and divergent development of posterior parietal cortex activation. Taken together, our data suggest that early adolescence may be a critical developmental period for prevention and intervention strategies addressing cognitive and phenotypic disinhibition. Nevertheless, further research examining multidimensional risk profiles in larger longitudinal datasets is needed to understand neurocognitive developmental mechanisms of problematic substance use onset and resilience across adolescence. Such a detailed understanding of neurodevelopmental factors of substance use vulnerability can clarify outcomes of adolescents with high-risk profiles and the etiology of early and escalating problematic substance use.
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[^1]: Equal Contribution

[^2]: **Note.**^a^Mean (standard deviation). ^b^Defined at baseline. ^c^Gender and age adjusted.

[^3]: **Note.** \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001. Categorical variables (FH and ETD) were coded as 1 for meeting risk criteria. Gender was coded with females as 1. Greater SES scores reflect higher SES. Correlation coefficients (parson: continuous-continuous associations; polyserial: continuous-categorical associations; polychoric: categorical-categorical) were generated from the polycor R package ([@bib0090]). Significance was determined using Pearson correlation for continuous-continuous associations, Welch's *t*-test for continuous-categorical associations, and chi-square testing for categorical-categorical associations.

[^4]: **Note.** \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001. Displayed test statistics are from models with the specific factor, age, visit, and trial condition (Reward, Neutral). ^a^Significant relationships when covarying for all risk factors. ^b^Significant relationships (p \< .05) when covarying for generalized cognitive ability (GA) and socioeconomic status (SES). Significant effects are bolded.

[^5]: **Note.** BA, Brodmann Area; K, number of voxels in cluster. X, Y, Z, peak voxel coordinates in MNI space; Mean cluster t-values from models predicting activation within clusters with a significant age interaction (voxelwise threshold p \< 0.005, number of contiguous voxels ≥ 20, p \< 0.05 corrected). All voxelwise models covaried for trial type (reward, neutral), visit, and session-wise average head. See Supplementary Table 4 for results at voxelwise threshold p \< .001, number of contiguous voxels \> 9, p \< .05 corrected.
